Device-based neuromodulation therapies may offer a viable alternative for patients with depression who do not achieve adequate response to SSRIs.

Medtech giant Abbott has secured a CE mark for two of its glucose-ketone sensing systems for diabetic patients, making the devices the first of their kind to reach this milestone.

Medtronic has recently announced superior results from a three-year study comparing the clinical outcomes of Medtronic’s Evolut and Edwards’ Sapien, the leading devices in the TAVR market.

ABILITY Neurotech has secured approval from the MREC NedMec in the Netherlands to initiate a chronic clinical trial of its fully implantable wireless BCI in patients with ALS.

AiM Medical Robotics is to develop an interface that will integrate its robotic neurosurgery platform with Siemens Healthineers’ MRI systems.

Jardine Matheson has agreed to acquire diagnostic imaging provider I-MED Radiology Network for an enterprise value of $2.4bn.

CSR's Sentire Endoscopic Surgical System has secured approval under the EU Medical Device Regulation with the CE mark, as well as a separate certification from Singapore HSA.

BioProtect’s lead product is a spacer system designed to protect healthy tissues during radiation therapies for prostate cancer treatment.

Hyperfine’s Swoop portable MRI system demonstrated a median imaging order to scan time of 6.35 hours versus conventional MRI.

Boston Scientific has announced a $1.5bn investment to acquire a 34% equity stake in implants and procedural solutions developer MiRus.

Endologix has acquired the Pounce mechanical thrombectomy system from Surmodics to expand its vascular intervention portfolio.

Sunrise Group has secured the US Food and Drug Administration (FDA) clearance for its latest rechargeable at-home sleep test, Sunrise Air.